SCHEMBL29909496

SCHEMBL29909496

COC(=O)c1ccc2c(c1)c(N(C)c1ccccc1)nc1nncn12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.42
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
CSNK2A1 P68400 3/20 0.38
ALDH1A1 P00352 4/20 0.37
TDP1 Q9NUW8 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
GLA P06280 1/20 0.37
HPGD P15428 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
MAPK1 P28482 1/20 0.37
CSNK2A2 P19784 2/20 0.36
CSNK2B P67870 2/20 0.36
HTT P42858 2/20 0.36
ALOX15 P16050 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23576749 1.00 FGFR1 (0.42) FGFR1GABRG2GABRB3GABRA5GABRA3
SCHEMBL23577421 0.92 CSNK2A1 (0.40) FGFR1GABRG2GABRB3GABRA5GABRA3
SCHEMBL29909863 0.92 CSNK2A1 (0.40) FGFR1GABRG2GABRB3GABRA5GABRA3
SCHEMBL29909942 0.89 CSNK2A1 (0.47) FGFR1CSNK2A1ALDH1A1HPGDMAPT
SCHEMBL23577221 0.89 CSNK2A1 (0.47) FGFR1CSNK2A1ALDH1A1HPGDMAPT
SCHEMBL23576897 0.87 CHEK2 (0.41) FGFR1CSNK2A1MAPTCSNK2A2CSNK2B
SCHEMBL29909675 0.87 CHEK2 (0.41) FGFR1CSNK2A1MAPTCSNK2A2CSNK2B
SCHEMBL23577364 0.87 GABRG2 (0.41) GABRG2GABRB3GABRA5GABRA3L3MBTL1
SCHEMBL29909321 0.87 GABRG2 (0.41) GABRG2GABRB3GABRA5GABRA3L3MBTL1
SCHEMBL23577048 0.81 CSF1R (0.49) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12054490-B2 Diacylglycerol kinase modulating compounds GILEAD SCIENCES, INC. (US) 2024-08-06 US disclosed
CN-118324767-A Diacylglycerol kinase modulating compounds 卡尔那生物科学株式会社 2024-07-12 CN disclosed
EP-4081305-A1 DIACYLGLYCEROL KINASE MODULATING COMPOUNDS Carna Biosciences, Inc. (JP) 2022-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12054490-B2 Diacylglycerol kinase modulating compounds DGKG, DGKB, DGKK FGFR1 2969/4885GABRG2 3044/4885GABRB3 3198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.